ABN 16 165 160 841 +61 (0) 3 9123 1140 | [email protected] Level 5, 90 William Street, Melbourne VIC 3000 Australia www.ampliatx.com 16 SEPTEMBER 2026 ASX RELEASE AMPLIA PRESENTS AT E&P HEALTHCARE CONFERENCE 2026 Melbourne, Australia: Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), is...
Amplia Presents at E&P Healthcare Conference 2026
Filed with ASX · · 29 pages · English
Release
Amplia Therapeutics Ltd. on 6ix
In the deck
Earlier from Amplia Therapeutics
- Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial
- Notification regarding unquoted securities - ATX
- Results of Annual General Meeting
- CEO Managing Director Presentation to Annual General Meeting
- Bioshares Biotech Summit Presentation
Later from Amplia Therapeutics
- Amplia Presents at CG Drug and Device Conference 2026
- Response to ASX Price Query
- Amplia Therapeutics Provides Clinical Trial Updates
- Amplia Receives R&D Tax Rebate Totalling $4.78 Million
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics